NCM
AZN icon

New Capital Management’s AstraZeneca AZN Stock Holding History

New Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-38
Closed -$4K – 122
2020
Q2 		$4K Hold
38
– – 0.01% 112
2020
Q1 		$3K Hold
38
– – 0.01% 95
2019
Q4 		$4K Hold
38
– – 0.01% 121
2019
Q3 		$3K Buy
+38
New +$3.29K ﹤0.01% 120

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

New Capital Management's AZN Position: Q3 2020 in Review

New Capital Management sold out of AstraZeneca (AZN) in Q3 2020, closing a stake of 38 shares — an estimated $4K sold.

New Capital Management first reported a position in AZN in Q3 2019 and held it in 4 quarters. The position peaked at $4K in Q2 2020. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • New Capital Management reported no remaining AstraZeneca position as of Q3 2020 after selling out during the quarter.
  • New Capital Management sold 38 AstraZeneca shares in Q3 2020, an estimated $4K.
  • New Capital Management first reported a position in AstraZeneca in Q3 2019 and held it in 4 quarters.
  • New Capital Management's AstraZeneca position peaked at $4K in Q2 2020.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on New Capital Management's 13F filing for Q3 2020, filed 9 Oct 2020.